Naumann d'Alnoncourt C, Lüderitz B
Dtsch Med Wochenschr. 1979 Jul 13;104(28):1009-14. doi: 10.1055/s-0028-1129028.
A recently developed antitachycardic pacemaker was implanted into seven patients with drug-resistant tachycardias. The implantation was made after diagnosis of a tachy-arrhythmia by invasive techniques and after experimental determination of the effective site, optimal mode and effective frequency of stimulation, as well as the regulation and duration of impulse release. Thus the pacemakers were individually adapted to the particular arrhythmia. High-frequency stimulation and competitive stimulation were used as stimulation modes. The systems work automatically, triggered either by the ECG, the patient or externally. The frequency of attacks was significantly reduced in five patients, the duration of attacks in all.
一种最近研发的抗心动过速起搏器被植入了7名患有抗药性心动过速的患者体内。植入手术是在通过侵入性技术诊断出心律失常，并通过实验确定有效部位、最佳刺激模式、有效刺激频率以及脉冲释放的调节和持续时间之后进行的。因此，起搏器是根据特定的心律失常进行个性化调整的。高频刺激和竞争性刺激被用作刺激模式。该系统能自动工作，由心电图、患者自身或外部触发。5名患者的发作频率显著降低，所有患者的发作持续时间均有所缩短。
